Arovella Therapeutics Limited Stock
Stocks
ALA
AU0000182784
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
21:00:23 2026-10-25 EDT
|
5-day change | 1st Jan Change | ||
| 0.0490 AUD | -3.92% |
|
-3.92% | -47.31% |
| 10-06 | Arovella Therapeutics Says Second Clinical Batch of ALA-101 Manufactured and Released | MT |
| 08-20 | Arovella Therapeutics Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| Market Cap | 59.23M 41.57M 37.17M 34.39M 31.14M 58.28M 3.96B 414M 164M 2.07B 156M 153M 6.55B | P/E 2025 |
-14.6x | P/E 2026 | -10.7x |
|---|---|---|---|---|---|
| Enterprise Value | 44.88M 31.5M 28.17M 26.06M 23.59M 44.16M 3B 314M 124M 1.57B 118M 116M 4.96B | EV / Sales 2025 |
28.4x | EV / Sales 2026 | 17.3x |
| Free-Float |
76.52% | Yield 2025 * |
-
| Yield 2026 | - |
Australian S.E.AUD
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| ALA | Delayed | |
Deutsche Boerse AG
| E4NA | Delayed | |
|
Börse Stuttgart
| E4NA | Delayed |
| 1 day | -3.92% | ||
| 1 week | -3.92% | ||
| Current month | +2.08% | ||
| 1 month | -9.26% | ||
| 3 months | -23.44% | ||
| 6 months | -36.36% | ||
| Current year | -47.31% |
| 1 week | 0.05 |  | 0.05 |
| 1 month | 0.05 | | 0.06 |
| Current year | 0.05 | | 0.1 |
| 1 year | 0.05 | | 0.1 |
| 3 years | 0.05 | | 0.21 |
| 5 years | 0.02 | | 0.21 |
| 10 years | 0.02 | | 0.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2026-05-06 | |
Lachie Mallia
DFI | Director of Finance/CFO | - | 2026-01-21 |
Simon Poon
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Williams
CHM | Chairman | 72 | 2026-05-03 |
Mark Diamond
BRD | Director/Board Member | - | 2026-04-27 |
Michael Thurn
BRD | Director/Board Member | - | 2026-04-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/24/25 | Exercice | Chairman | 1,157,647 | 0.0966% | ||
| 11/24/25 | Exercice | Chairman | 1,242,353 | 0.1036% | ||
| 11/12/25 | Exercice | Director | 1,013,333 | 0.0845% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.92% | -3.92% | -45.56% | -44.32% | 43.36M | |
| +0.88% | +1.18% | +40.64% | +74.91% | 64.69B | |
| -0.26% | +6.91% | +9.79% | +77.36% | 54.78B | |
| +0.47% | +3.52% | +9.71% | +100.95% | 53.49B | |
| -1.55% | +3.56% | +26.63% | +49.30% | 45.98B | |
| -1.72% | +0.41% | +17.83% | +124.11% | 42.94B | |
| -1.62% | +1.52% | +218.87% | +828.73% | 40.08B | |
| -2.26% | -2.06% | +15.38% | +45.14% | 33.52B | |
| +0.22% | -4.77% | +26.59% | +0.55% | 23.97B | |
| +12.10% | +16.60% | +58.50% | +46.15% | 23.67B | |
| Average | +0.24% | +2.00% | +37.84% | +130.29% | 38.32B | |
| Weighted average by Cap. | +0.20% | +2.59% | +44.32% | +151.14% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.44M 2.41M 2.16M 2M 1.81M 3.38M 230M 24.03M 9.51M 120M 9.06M 8.87M 380M | 3.5M 2.45M 2.2M 2.03M 1.84M 3.44M 234M 24.44M 9.67M 122M 9.21M 9.02M 387M |
| Net income | -7.51M -5.27M -4.71M -4.36M -3.95M -7.39M -501M -52.46M -20.75M -262M -19.78M -19.36M -830M | -6.92M -4.85M -4.34M -4.02M -3.64M -6.8M -462M -48.32M -19.11M -242M -18.22M -17.83M -765M |
| Net Debt | -20.88M -14.65M -13.1M -12.12M -10.97M -20.54M -1.39B -146M -57.7M -729M -54.99M -53.82M -2.31B | -14.35M -10.07M -9.01M -8.33M -7.55M -14.12M -958M -100M -39.67M -501M -37.81M -37M -1.59B |
Employees
27
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-25 | A$0.0490 | -3.92% | 106,211 |
| 26-10-23 | A$0.0510 | +4.08% | 257,548 |
| 26-10-22 | A$0.0490 | -3.92% | 1,273,599 |
| 26-10-21 | A$0.0510 | +2.00% | 1,306,659 |
| 26-10-20 | A$0.0500 | -1.96% | 16,200 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALA Stock
Select your edition
All financial news and data tailored to specific country editions
